Document Detail

The effect of mother-infant skin-to-skin contact on infants' response to the Still Face Task from newborn to three months of age.
MedLine Citation:
PMID:  22245110     Owner:  NLM     Status:  Publisher    
The effect of mother-infant skin-to-skin contact on infants' developing social expectations for maternal behavior was investigated longitudinally over infants' first 3 months. Infants with and without skin-to-skin contact engaged with their mothers in the Still Face Task at ages 1week, 1 month, 2 months, and 3 months. Infants with skin-to-skin contact began responding to changes in their mothers' behavior with their affect at 1 month; infants without skin-to-skin contact did so at 2 months. At 3 months, infants with skin-to-skin contact increased their non-distress vocalizations during the still face phase, suggesting social bidding to their mothers. Skin-to-skin contact accelerated infants' social expectations for their mothers' behavior and enhanced infants' awareness of themselves as active agents in social interactions.
Ann E Bigelow; Michelle Power
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-13
Journal Detail:
Title:  Infant behavior & development     Volume:  -     ISSN:  1934-8800     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7806016     Medline TA:  Infant Behav Dev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Department of Psychology, St. Francis Xavier University, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Environmental exposure to benzene, micronucleus formation and polymorphisms in DNA-repair genes: A p...
Next Document:  Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target...